MedPath

Brief Problem-solving Intervention in Different Formats for the Prevention of Suicide in Adults Over 50

Not Applicable
Active, not recruiting
Conditions
Suicide
Interventions
Behavioral: Problem-solving-based psychological intervention
Registration Number
NCT06338904
Lead Sponsor
University of Santiago de Compostela
Brief Summary

Suicide represents a personal tragedy and an enormous global public health problem. One of the most vulnerable groups is adults 50 years and older. Despite this stage of life is particularly amenable to the implementation of targeted suicide prevention strategies, we have few studies of the efficacy of psychological interventions, those that do exist have methodological limitations, and none were implemented in formats other than face-to-face, which limits their accessibility. There is a need for brief psychological interventions that can be administered in both face-to-face and remote formats, do not require long training periods, and are effective in different contexts: for example, problem-solving therapy. The main objective of this project is to evaluate the efficacy of a brief problem-solving psychological intervention for targeted suicide prevention in people aged 50 years and older, administered in face-to-face, conference call, and smartphone app formats. A randomized controlled trial will be performed. Participants will be recruited through healthcare centers in the Autonomous Community of Galicia (Spain). To be included, participants must: (a) be at least 50 years old, (b) reside in Galicia, and (c) present suicidal ideation. Subjects will be excluded if they: (a) present serious mental health or medical disorders; (b) have begun receiving psychological or psychopharmacological treatment in the previous two months or are participating in other suicide prevention research; (c) do not have an appropriate mobile device or sufficient fluency to communicate in Spanish, or have problems that make it impossible to participate; or (d) plan to move in the next 18 months. At pre-intervention information will be collected on sociodemographic, family, personal history, current suicide risk and other clinical variables. 212 participants will be randomly assigned to (1) a problem-solving-based psychological intervention delivered face-to-face (PSPI-FF; experimental group 1); (2) a problem-solving-based psychological intervention delivered via telephone conference call (PSPI-CC; experimental group 2); (3) a problem-solving-based psychological intervention delivered via a smartphone app (PSPI-A; experimental group 3); or (4) a usual care control group (UCCG). Participants in the experimental groups will complete the six sessions/modules of the interventions. Finally, subjects in all groups will be evaluated at post-intervention and 3, 6 and 12-month follow-ups.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
212
Inclusion Criteria
  • Be at least 50 years old
  • Reside in Galicia
  • Present suicidal ideation
Exclusion Criteria
  • Present serious mental health or medical disorders
  • Have begun receiving psychological or psychopharmacological treatment in the previous two months or are participating in other suicide prevention research
  • Do not have an appropriate mobile device or sufficient fluency to communicate in Spanish, or have problems that make it impossible to participate
  • Plan to move in the next 18 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Problem-solving-based psychological intervention delivered via a smartphone app (PSPI-A)Problem-solving-based psychological interventionParticipants in this group will receive the intervention described adapted to be administered through a smartphone app, with equivalent duration, content, and structure (approximately 90 minutes to complete each of the 6 modules).
Problem-solving-based psychological intervention delivered via telephone conference call (PSPI-CC)Problem-solving-based psychological interventionParticipants in this group will receive the intervention described in a teleconference call format, with the same duration, contents, and structure.
Problem-solving-based psychological intervention delivered in a face-to-face format (PSPI-FF)Problem-solving-based psychological interventionParticipants in this group will receive a problem-solving intervention for suicide prevention in a face-to-face format. The intervention will consist of 6 sessions, approximately 90 minutes in duration each, once a week, in a group format, in person.
Primary Outcome Measures
NameTimeMethod
Change from baseline suicidal ideation to post-treatment (7 weeks), and follow-ups at 6 and 12 months.Pre- and post-intervention (7 weeks) with follow-ups at 3, 6 and 12 months

Aditionally, the severity of ideation and suicidal behavior over the last month will be assessed using the Columbia Scale for assessing suicide risk (C-SSRS; Posner et al., 2011). It consists of a semi-structured interview with good convergent and discriminant validity and high sensitivity (100.0%) and specificity (99.4%) for the classification of suicidal behavior; the ideation intensity subscale showed a Cronbach's alpha of .73-.95.

Secondary Outcome Measures
NameTimeMethod
Change from baseline reasons for living to post-treatment (7 weeks), and follow-ups at 6 and 12 monthsPre- and post-intervention (7 weeks) with follow-ups at 3, 6 and 12 months

Deterrent reasons for attempting suicide will be assessed through the Reasons for Living Inventory (RFL; Linehan et al., 1983), a self-administered instrument of 48 items across six subscales, with a range from 48 to 288. Higher scores mean that individuals exhibit higher reasons for living. Internal consistencies (Cronbach's alphas) range from .72 to .89.

Change from baseline impulsivity to post-treatment (7 weeks), and follow-ups at 6 and 12 monthsPre- and post-intervention (7 weeks) with follow-ups at 3, 6 and 12 months

Impulsivity will be assessed using the Barratt Impulsiveness Scale (BIS-11; Patton et al., 1995), a self-administered instrument of 30 items, with a range from 30 to 120. Higher scores mean higher impulsivity. Its internal consistencies (Cronbach's alphas) range from .79 to .82.

Change from baseline hopelessness to post-treatment (7 weeks), and follow-ups at 6 and 12 monthsPre- and post-intervention (7 weeks) with follow-ups at 3, 6 and 12 months

Hopelessness will be assessed with the Beck Hopelessness Scale (HS; Beck et al., 1974), a self-administered instrument of 20 items with a range from 0 to 20. Higher scores mean higher hopelessness. It has an internal consistency (Kuder-Richardson 20 \[KR-20\]) of .93.

Change from baseline anxiety and depressive symptoms to post-treatment (7 weeks), and follow-ups at 6 and 12 monthsPre- and post-intervention (7 weeks) with follow-ups at 3, 6 and 12 months

Anxiety and depression symptoms will be assessed with the General Health Questionnaire (GHQ-12; Goldberg \& Williams, 1988), a self-administered questionnaire of 12 items designed to screen for non-psychotic psychiatric morbidity, with a range from 0 to 12. Higher scores mean higher anxiety and depressive symptoms. Its internal consistency (Cronbach's alpha) is .86 for individuals under 65 years of age and .90 for individuals aged 65 years or older.

Satisfaction with the service receivedPost-intervention (7 weeks)

Satisfaction with the intervention will be evaluated using the Client Satisfaction Questionnaire (CSQ-8; Larsen et al., 1979), an 8-item scale whose total score varies from 8 to 32, where a higher score indicates greater satisfaction with the service received. It has an internal consistency (Cronbach's alpha) of .80.

Change from baseline problem-solving skills to post-treatment (7 weeks), and follow-ups at 6 and 12 monthsPre- and post-intervention (7 weeks) with follow-ups at 3, 6 and 12 months

Problem-solving skills will be assessed with the Revised Social Problem-Solving Inventory (SPSI-R; D'Zurilla et al., 1997), an inventory of 52 items with a range from 0 to 208, and an internal consistency (Cronbach's alpha) ranging from .68 to .92.

Treatment adherenceDuring the intervention sessions (6 weeks)]

Treatment adherence will be assessed by recording the number of sessions attended or modules completed by each participant, and the number of intersession tasks completed.

Change from baseline syndrome of clinical anger to post-treatment (7 weeks), and follow-ups at 6 and 12 monthsPre- and post-intervention (7 weeks) with follow-ups at 3, 6 and 12 months

The anger syndrome will be assessed with the Clinical Anger Scale (CAS; Snell et al., 1995), a self-administered instrument of 21 items with a range from 0 to 63, and an internal consistency (Cronbach's alpha) of .94. Higher scores correspond to greater clinical anger.

Change from baseline social support to post-treatment (7 weeks), and follow-ups at 6 and 12 monthsPre- and post-intervention (7 weeks) with follow-ups at 3, 6 and 12 months

Social support will be evaluated with the DUKE-UNC Functional Social Support Questionnaire (Duke-UNC-11; Broadhead et al., 1988), an 11-item questionnaire with a range from 11 to 55 and an internal consistency (Cronbach's alpha) of .90. Higher scores mean higher social support.

Trial Locations

Locations (1)

Research Group on Mental Health and Psychopatology

🇪🇸

Santiago de Compostela, A Coruña, Spain

© Copyright 2025. All Rights Reserved by MedPath